【代表性论文】
1. Sun, W.#, Guo, S.#(共同一作), Li, Y.#, et al. Anoctamin 1
controls bone resorption by coupling Cl− channel activation with RANKL-RANK signaling
transduction[J], Nature Communications, 2022, 13(1):2899.
2. Bai, X., Liu, X., Li, S., An,
H., Kang, X., Guo, S.*. Caffeic Acid,
an Active Ingredient in Coffee, Combines with DOX for Multitarget Combination
Therapy of Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(27):8326-8337.
3. Guo, S., Bai, X., Shi, S., et al. Multi-target tracheloside and doxorubicin
combined treatment of lung adenocarcinoma[J], Biomedicine & pharmacotherapy,
2022, 153:113392.
4. Bai, X., Li, S., Liu, X., An,
H., Kang, X., Guo, S.*. Nuciferine Inhibits TMEM16A in Dietary Adjuvant
Therapy for Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(12):3687-3696.
5. Chang, L., Chang, R., Shen J.,
Wang, Y., Song, H., Kang, X., Zhao. Y., Guo, S.*, Qin, J*. Self-healing
pectin/cellulose hydrogel loaded with limonin as TMEM16A inhibitor for lung
adenocarcinoma treatment[ J]. International Journal of Biological
Macromolecules, 2022, 219: 754-766.
6. Guo,
S., Bai, X., Shi, S., et al. TMEM16A, a homoharringtonine receptor, as a
potential endogenic target for lung cancer treatment[J], International Journal
of Molecular Sciences, 2021, 22(20):10930.
7. Guo, S., Bai, X., Liu, Y.F., et al. Inhibition of TMEM16A by natural product
silibinin: potential lead compounds for treatment of lung adenocarcinoma[J],
Frontiers in Pharmacology, 2021, 12: 643489.
8. Guo, S., Chen, Y.F., Shi, S., et al. Arctigenin, a novel TMEM16A inhibitor for
lung adenocarcinoma therapy[J], Pharmacological Research, 2020, 155: 104721.
9. Guo, S., Chen, Y.F., Shi, S., et al. The molecular mechanism of ginsenoside
analogs activating TMEM16A[J], Biophysical Journal, 2020, 118(1): 262-272.
10. Guo, S., Qiu, L., Chen, Y.F., et al. TMEM16A-inhibitor loaded pH-responsive
nanoparticles: a novel dual-targeting antitumor therapy for lung
adenocarcinoma[J], Biochemical Pharmacology, 2020,178:114062.
11. Guo, S., Wang, H., Pang, C.L., et al. Entering the spotlight: chitosan
oligosaccharides as novel activators of CaCCs/TMEM16A[J], Pharmacological
Research, 2019, 146: 104323.
12. Guo,
S., Chen, Y.F., Pang, C.L., et al. Matrine is a novel inhibitor of the
TMEM16A chloride channel with antilung adenocarcinoma effects[J], Journal of
Cellular Physiology, 2019, 234(6): 8698-8708.
13. Guo,
S., Chen, Y.F., Pang, C.L., et al. Ginsenoside Rb1, a novel activator of
the TMEM16A chloride channel, augments the contraction of guinea pig ileum[J],
Pflugers Archiv : European Journal of Physiology, 2017, 469(5-6): 681-692.
14. Hao, A.Q.#, Guo, S.#(共同一作), Shi, S., et al. Emerging modulators of TMEM16A
and their therapeutic potential[J], The Journal of Membrane Biology, 2021,
254(4): 353-365.
15. Huang, Y.Y.#, Guo, S.#(共同一作), Ren, S.X., et al. The
natural compound cinnamaldehyde is a novel activator of calcium-activated
chloride channel[J], The Journal of Membrane Biology, 2018, 251(5-6):
747-756.3.
